189 related articles for article (PubMed ID: 38142899)
1. Comprehensive reproductive healthcare for women with immune-mediated inflammatory diseases: Addressing rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease through life's stages.
Andreoli L; Guadagni I; Picarelli G; Principi M
Autoimmun Rev; 2024 Mar; 23(3):103507. PubMed ID: 38142899
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.
Rizzello F; Olivieri I; Armuzzi A; Ayala F; Bettoli V; Bianchi L; Cimino L; Costanzo A; Cristaudo A; D'Angelo S; Daperno M; Fostini AC; Galeazzi M; Gilio M; Gionchetti P; Gisondi P; Lubrano E; Marchesoni A; Offidani A; Orlando A; Pugliese D; Salvarani C; Scarpa R; Vecchi M; Girolomoni G
Adv Ther; 2018 Apr; 35(4):545-562. PubMed ID: 29516409
[TBL] [Abstract][Full Text] [Related]
3. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
4. [Immune-Mediated Inflammatory Diseases and accompanying comorbidities].
Majdan M
Wiad Lek; 2016; 69(4):611-615. PubMed ID: 27941197
[TBL] [Abstract][Full Text] [Related]
5. Drug Levels and Antibodies Against TNF-blockers in Spondyloarthritis and Rheumatoid Arthritis are Associated with the Activity but they do Not Predict it.
Padilla-Martínez EM; Romero-Sanchez C; Bello-Gualtero JM; Mesa-Betancourt AM; Bautista-Molano W; Valle-O R
Curr Rheumatol Rev; 2019; 15(4):329-335. PubMed ID: 31284866
[TBL] [Abstract][Full Text] [Related]
6. Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?
Aloush V; Dotan I; Ablin JN; Elkayam O
Clin Exp Rheumatol; 2019; 37(1):32-36. PubMed ID: 29998822
[TBL] [Abstract][Full Text] [Related]
7. The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus.
Macaluso FS; Caprioli F; Benedan L; Bezzio C; Caporali R; Cauli A; Chimenti MS; Ciccia F; D'Angelo S; Fantini MC; Festa S; Iannone F; Lubrano E; Mariani P; Papi C; Provenzano G; Pugliese D; Rispo A; Saibeni S; Salvarani C; Variola A; Zenga M; Armuzzi A; Orlando A; Gerli R
Autoimmun Rev; 2024 May; 23(5):103533. PubMed ID: 38521214
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.
Menegatti S; Bianchi E; Rogge L
Front Immunol; 2019; 10():382. PubMed ID: 30941119
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis.
Ono K; Kishimoto M; Deshpande GA; Fukui S; Kawaai S; Sawada H; Matsuura M; Rodriguez VR; Proft F; Tada K; Tamura N; Taniguchi Y; Hirata A; Kameda H; Tsuji S; Kaneko Y; Dobashi H; Okano T; Haji Y; Morita A; Okada M; Komagata Y; Medina CL; Molto A; Dougados M; Hisamatsu T; Tomita T; Kaname S
Rheumatol Int; 2022 Oct; 42(10):1751-1766. PubMed ID: 35532790
[TBL] [Abstract][Full Text] [Related]
10. Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.
Ben Nessib D; Ferjani H; Maatallah K; Rahmouni S; Kaffel D; Hamdi W
Clin Rheumatol; 2020 Dec; 39(12):3543-3553. PubMed ID: 32424656
[TBL] [Abstract][Full Text] [Related]
11. [Use of clinical scores for rheumatoid arthritis and inflammatory rheumatic diseases in routine care].
Schläpfer-Pessina A; Dumusc A
Rev Med Suisse; 2022 Mar; 18(773):462-466. PubMed ID: 35306765
[TBL] [Abstract][Full Text] [Related]
12. Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients.
Beauvais C; Rodère M; Pereira B; Legoupil N; Piperno M; Pallot Prades B; Castaing P; Wendling D; Grange L; Costantino F; Carton L; Soubrier M; Coquerelle P; Pham T; Poivret D; Cohen JD; Tavares I; Nataf H; Pouplin S; Sordet C; Gossec L
Joint Bone Spine; 2019 Nov; 86(6):747-752. PubMed ID: 31228620
[TBL] [Abstract][Full Text] [Related]
13. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D;
Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440
[TBL] [Abstract][Full Text] [Related]
14. The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper.
Fiorino G; Girolomoni G; Lapadula G; Orlando A; Danese S; Olivieri I;
Autoimmun Rev; 2014 Jul; 13(7):751-5. PubMed ID: 24657898
[TBL] [Abstract][Full Text] [Related]
15. Role of stem cells in spondyloarthritis: Pathogenesis, treatment and complications.
Wong RS
Hum Immunol; 2015 Oct; 76(10):781-8. PubMed ID: 26429327
[TBL] [Abstract][Full Text] [Related]
16. Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease.
Urruticoechea-Arana A; Sanz J; Ginard D; González-Lama Y; Juanola X; Almirall M; Borruel N; Gratacós J; Loza E
Reumatol Clin (Engl Ed); 2023 Oct; 19(8):423-429. PubMed ID: 37805255
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Dietary Supplements in Inflammatory Bowel Disease and Related Autoimmune Diseases.
Jadhav P; Jiang Y; Jarr K; Layton C; Ashouri JF; Sinha SR
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32698454
[TBL] [Abstract][Full Text] [Related]
18. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
Wang CR; Tsai HW
World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
Cai D; Zheng Z; Hu J; Fu Y; Song Y; Lian J
Clin Rheumatol; 2024 Jan; 43(1):533-541. PubMed ID: 37505304
[TBL] [Abstract][Full Text] [Related]
20. Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
Simader E; Tobudic S; Mandl P; Haslacher H; Perkmann T; Nothnagl T; Sautner J; Radner H; Winkler F; Burgmann H; Mrak D; Aletaha D; Winkler S; Blüml S
Ann Rheum Dis; 2022 Mar; 81(3):416-421. PubMed ID: 34844927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
